Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2871780 | The Annals of Thoracic Surgery | 2015 | 11 Pages |
Abstract
Moderate or severe CLD is associated with an increased risk of death to 1-year after TAVR, and among patients with severe CLD, the risk of death appears to be similar with either transapical or transaortic alternate-access approaches. Further study is necessary to understand strategies to mitigate risk associated with CLD and the long-term implications of these findings.
Keywords
FEV1Placement of Aortic Transcatheter Valve trialtransaorticTAVRTVTTAONYHAACCCMSCLDSTSNew York Heart AssociationChronic obstructive pulmonary diseaseCOPDChronic lung diseasetransfemoraltransapicalTranscatheter aortic valve replacementThe Society of Thoracic Surgeonstranscatheter valve therapyPartnerforced expiratory volume in 1 secondCenters for Medicare and Medicaid ServicesAmerican College of Cardiology
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rakesh M. MD, DPhil, Brian C. MD, J. Matthew MD, MPH, Vinod H. MD, Dadi PhD, Alan MD, Kevin L. MD, Christina M. MD, Verghese MD, Vuyisile T. MD, MPH, Michael J. MD, Charanjit S. MD, Lars G. MD, PhD, Rick A. MD, Patrick T. MD, David R. MD,